Evidence map›Paper›PMID 42440083›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Image quality and lesion detectability in simulated [

Foroud Aghapour Zangeneh, Konstantinos Zeimpekis, Silvano Gnesin, Luisa Maria Knappe, Valentina Garibotto, Christel H Kamani, John O Prior, Axel Rominger, Federico Caobelli

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Foroud Aghapour ZangenehDepartment of Nuclear Medicine, Inselspital, Bern University Hospital and University of Bern, Rosenbühlgasse 25/27, 3010, Bern, Switzerland.
Konstantinos ZeimpekisDepartment of Nuclear Medicine, Inselspital, Bern University Hospital and University of Bern, Rosenbühlgasse 25/27, 3010, Bern, Switzerland.
Silvano GnesinInstitute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Luisa Maria KnappeDivision of Nuclear Medicine and Molecular Imaging, University Hospitals of Geneva, Geneva, Switzerland.
Valentina GaribottoDivision of Nuclear Medicine and Molecular Imaging, University Hospitals of Geneva, Geneva, Switzerland.
Christel H KamaniDepartment of Cardiology, Lausanne University Hospital, Lausanne, Switzerland.
John O PriorDepartment of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland.
Axel RomingerDepartment of Nuclear Medicine, Inselspital, Bern University Hospital and University of Bern, Rosenbühlgasse 25/27, 3010, Bern, Switzerland.
Federico CaobelliDepartment of Nuclear Medicine, Inselspital, Bern University Hospital and University of Bern, Rosenbühlgasse 25/27, 3010, Bern, Switzerland. Federico.caobelli@unibe.ch.ORCID http://orcid.org/0000-0003-2472-775X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac sympathetic imaging with iodine-labeled metaiodobenzylguanidine (MIBG) is clinically relevant for assessing autonomic dysfunction and arrhythmic risk in heart failure. The development of positron-emitting

methodsAn anthropomorphic torso phantom with cardiac insert was prepared to simulate physiologic

resultsLAFOV PET/CT showed the best qualitative and quantitative performance overall. Lesion detectability was highest on LAFOV at all acquisition times, with digital SAFOV intermediate and analog SAFOV lowest. Image quality likewise favored LAFOV, especially at 5 and 10 min. In the pathological phantom, SNR increased from 25.9 to 75.1 on LAFOV, from 18.7 to 41.8 on digital SAFOV, and from 15.5 to 17.1 on analog SAFOV. At 10 min, exploratory uncorrected pairwise comparisons showed nominally higher SNR on LAFOV than on analog SAFOV PET/CT (75.1 vs 17.1, p = 0.028). For the transmural defect, CNR also increased most on LAFOV, with a nominally higher value versus analog SAFOV at 10 min (67.6 vs 14.5, p = 0.044). By contrast, for the low-contrast non-transmural defect, CNR was numerically higher on LAFOV at longer acquisition times, but the absolute inter-scanner differences were smaller and did not reach statistical significance.

conclusionLAFOV PET/CT provides superior image quality and lesion detectability for simulated cardiac

Indexed as

3-IodobenzylguanidineHeartPhantoms, ImagingPositron Emission Tomography Computed TomographyHumansImage Processing, Computer-AssistedIodine RadioisotopesSignal-To-Noise RatioTime Factors3-IodobenzylguanidineIodine-124Iodine Radioisotopes124I-MIBG PET/CTAnalog PETCardiac sympathetic imagingLAFOV PETSAFOV PET

Identifiers

PMID42440083
PMCPMC13633159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.